Biocatalysts and Methods for the Synthesis of Armodafinil

Codexis, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 11 of these applications claim priority to application 13/992,138, filed Jun 6, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 9,765,306	Biocatalysts and Methods for the Synthesis of Armodafinil Codexis, Inc. In force Term ends Dec 8, 2030 · High confidence	Codexis, Inc.	In force	Term ends Dec 8, 2030	Term ends Dec 8, 2030	High confidence
US 9,938,509	Biocatalysts and Methods for the Synthesis of Armodafinil Codexis, Inc. In force Term ends Dec 8, 2030 · High confidence	Codexis, Inc.	In force	Term ends Dec 8, 2030	Term ends Dec 8, 2030	High confidence
US 10,087,426	Polynucleotides Encoding Cyclohexanone Monooxygenases Codexis, Inc. In force Term ends Dec 8, 2030 · High confidence	Codexis, Inc.	In force	Term ends Dec 8, 2030	Term ends Dec 8, 2030	High confidence
US 10,400,223	Biocatalysts and Methods for the Synthesis of Armodafinil Codexis, Inc. In force Term ends Dec 8, 2030 · High confidence	Codexis, Inc.	In force	Term ends Dec 8, 2030	Term ends Dec 8, 2030	High confidence
US 10,557,126	Polynucleotides Encoding Cyclohexanone Monooxygenases Codexis, Inc. In force Term ends Dec 8, 2030 · High confidence	Codexis, Inc.	In force	Term ends Dec 8, 2030	Term ends Dec 8, 2030	High confidence
US 10,781,429	Biocatalysts and Methods for the Synthesis of Armodafinil Codexis, Inc. In force Term ends Dec 8, 2030 · High confidence	Codexis, Inc.	In force	Term ends Dec 8, 2030	Term ends Dec 8, 2030	High confidence
US 10,961,517	Biocatalysts and Methods for the Synthesis of Armodafinil Codexis, Inc. In force Term ends Dec 8, 2030 · High confidence	Codexis, Inc.	In force	Term ends Dec 8, 2030	Term ends Dec 8, 2030	High confidence
US 11,384,343	Biocatalysts and Methods for the Synthesis of Armodafinil Codexis, Inc. In force Term ends Dec 8, 2030 · High confidence	Codexis, Inc.	In force	Term ends Dec 8, 2030	Term ends Dec 8, 2030	High confidence
US 12,344,866	Biocatalysts and Methods for the Synthesis of Armodafinil Codexis, Inc. In force Term ends Dec 8, 2030 · High confidence	Codexis, Inc.	In force	Term ends Dec 8, 2030	Term ends Dec 8, 2030	High confidence
US 9,528,095	Biocatalysts and Methods for the Synthesis of Armodafinil Codexis, Inc. In force Term ends Jul 24, 2031 · High confidence	Codexis, Inc.	In force	Term ends Jul 24, 2031	Term ends Jul 24, 2031	High confidence
1 more patent in this group · Pro

10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Pro members see all 11.

Upgrade to Pro

Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.